FDA Adverse Event Injury Summary report: N

CRYSTALENS

MDR report key: 2010958 · Received March 4, 2011

Report

Report Number
2031924-2011-00051
Event Type
Injury
Date Received
March 4, 2011
Report Date
February 2, 2011
Manufacturer
BAUSCH + LOMB
Product Code
NAA
PMA / PMN Number
P030002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE INTRAOCULAR LENS IS IMPLANTED. THE DEVICE HISTORY RECORDS WERE REVIEWED AND THERE WERE NO DISCREPANCIES OR UNUSUAL FINDINGS THAT RELATE TO THE REPORTED ISSUE.

Description of Event or Problem · 1

BAUSCH + LOMB RECEIVED A COMPLAINT FROM A CONSUMER WHO IS DISSATISFIED WITH VISUAL OUTCOME AFTER IMPLANTATION OF CRYSTALENS INTRAOCULAR LENSES IN BOTH EYES. THIS REPORT REFERS TO THE RIGHT EYE. THE PATIENT EXPERIENCED POOR INTERMEDIATE AND NEAR VISION IN THE RIGHT EYE POSTOPERATIVELY. ALSO, THE PATIENT REPORTS HAVING BEEN PRESCRIBED TOPICAL STEROIDAL/NSAID DROPS TO TREAT SUSPECTED RETINAL EDEMA. ADDITIONAL INFORMATION RECEIVED FROM THE SURGEON INDICATES THAT THE IOL IS FREE OF DEBRIS/DEPOSITS, AND THERE WERE NO COMPLICATIONS OF THE ORIGINAL SURGICAL PROCEDURE. ALSO, THE PATIENT UNDERWENT YAG LASER CAPSULOTOMY FOR THE RIGHT EYE. PREOPERATIVELY, THE PATIENT'S BCVA WAS 20/25 WITH MR OF -5.00 -0.50 X080. POSTOPERATIVELY, THE PATIENT'S BEST CORRECTED VISUAL ACUITY IS 20/20 WITH MR OF PLANO +0.50 X 90. REFERENCE MDR # 2031924-2011-00050.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CRYSTALENS INTRAOCULAR LENS NAA BAUSCH + LOMB AT52AO 019237

Patients

Seq Age Sex Outcome Treatment
1 64 YR Other